Treace Medical Concepts, Inc.

NasdaqGS:TMCI Stock Report

Market Cap: US$714.1m

Treace Medical Concepts Past Earnings Performance

Past criteria checks 0/6

Treace Medical Concepts's earnings have been declining at an average annual rate of -52.7%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 37.1% per year.

Key information

-52.7%

Earnings growth rate

-45.3%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate37.1%
Return on equity-35.9%
Net Margin-26.5%
Next Earnings Update07 May 2024

Recent past performance updates

Recent updates

Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Apr 05
Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?

Feb 09
Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge

Jan 04
Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge

Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower

Nov 11
Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower

Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results

Aug 13
Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results

Revenue & Expenses Breakdown
Beta

How Treace Medical Concepts makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:TMCI Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23187-5018815
30 Sep 23175-4817315
30 Jun 23167-4216114
31 Mar 23155-4715114
31 Dec 22142-4313814
30 Sep 22126-4512613
30 Jun 22114-3911212
31 Mar 22105-279711
31 Dec 2194-218410
30 Sep 2185-12679
30 Jun 2178-8578
31 Mar 2165-5446
31 Dec 2057-4386
31 Dec 1939-5305

Quality Earnings: TMCI is currently unprofitable.

Growing Profit Margin: TMCI is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: TMCI is unprofitable, and losses have increased over the past 5 years at a rate of 52.7% per year.

Accelerating Growth: Unable to compare TMCI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TMCI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).


Return on Equity

High ROE: TMCI has a negative Return on Equity (-35.91%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.